STUDY OF MINIMAL RESIDUAL DISEASE BY MULTICOLOR FLOW CYTOMETRY IN MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Irina Galtseva(National Research Center for Preventive Medicine), Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Larisa A. Kuzmina(Ministry of Health of the Russian Federation), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Н. М. Капранов(National Research Center for Preventive Medicine), Е О Грибанова, M. V. Solovev(Ministry of Health of the Russian Federation), T. V. Gaponova(National Medical Research Center for Hematology), Yulia Davydova(National Research Center for Preventive Medicine)
Cited by 2
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59